STUDIES IN MYCOLOGY is a premier journal dedicated to advancing research in the field of mycology, published by the renowned WESTERDIJK FUNGAL BIODIVERSITY INSTITUTE. With an impact factor that places it in the top quartile (Q1) of both Agricultural and Biological Sciences and Plant Science categories, it holds a prestigious position in the scientific community, ranking #1 out of 193 in its field as per Scopus metrics. Since its transition to Open Access in 2008, it has made significant strides in disseminating high-quality research widely, fostering a greater understanding of fungal biodiversity and its ecological impact. Covering a broad spectrum of topics related to mycology, the journal aims to provide researchers, professionals, and students with a platform for sharing innovative findings, stimulating academic discourse, and promoting collaborative efforts within this vital area of study. Hailing from the Netherlands, STUDIES IN MYCOLOGY serves as an invaluable resource for exploring the complexities of fungi, their interactions with various ecosystems, and their practical applications in agriculture and beyond.

MYCOBIOLOGY is an esteemed open-access journal published by Taylor & Francis Ltd, specializing in the fields of Infectious Diseases, Microbiology, and Plant Science. Since its inception, the journal has provided a platform for innovative research, showcasing a diverse range of studies that delve into the complexities of mycology and its vast implications on health, agriculture, and the environment. With a commendable impact factor and a Q2 ranking in Plant Science as of 2023, MYCOBIOLOGY facilitates the dissemination of vital findings to a global audience of researchers, professionals, and students. In addition to its commitment to high-quality content, MYCOBIOLOGY has embraced open access since 2018, ensuring that the latest advancements in mycological research are readily available to the academic community and the public. By bridging gaps in knowledge and fostering collaboration across disciplines, MYCOBIOLOGY plays a crucial role in advancing our understanding of fungal biology and its myriad applications.

MEDICAL MYCOLOGY, published by Oxford University Press, is a premier journal dedicated to the study of fungal infections and their clinical implications. With an ISSN of 1369-3786 and an E-ISSN of 1460-2709, this journal has established itself as a vital resource in the fields of Infectious Diseases and Medicine, holding a respectable Q2 ranking for both categories and a Q1 ranking in the veterinary sector in 2023. Spanning a rich history from 1962 to 2024, MEDICAL MYCOLOGY serves as a platform for innovative research, case reports, and review articles that contribute to the understanding and management of mycological diseases. The journal's commitment to advancing knowledge is reflected in its Scopus rank of #120 out of 344 in Medicine - Infectious Diseases, positioning it within the 65th percentile. With open access options available, it aims to ensure that critical research is accessible to a global audience, enhancing collaboration and knowledge sharing among researchers, healthcare professionals, and students alike.

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

MYCOTAXON is a peer-reviewed journal dedicated to the field of mycology, focusing on the taxonomy, systematics, and ecology of fungi. Published by MYCOTAXON LTD, this journal plays a crucial role in advancing our understanding of fungal biodiversity and its significance within various ecosystems. Although it currently does not offer open access options, its contributions are vital to the scientific community, especially with its established presence since 1989. With an HIndex reflecting its relevance and attracting a dedicated readership, MYCOTAXON is recognized within the Q4 quartile in both Ecology, Evolution, Behavior, and Systematics, and Plant Science categories as of 2023. This places it among a critical cohort of journals that contribute to the understanding of ecological dynamics and plant-fungal interactions. Researchers, professionals, and students can benefit from the insights provided in MYCOTAXON, making it an indispensable resource for anyone involved in the study of fungi.

Fungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.

Journal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.

Fungal Genetics and Biology is a leading peer-reviewed journal published by Academic Press Inc, Elsevier Science, dedicated to advancing the understanding of fungi through innovative genetic and biological research. Since its inception in 1996, this journal has served as a vital platform for the dissemination of critical findings in the fields of Genetics and Microbiology, maintaining a distinguished Q2 category ranking in both disciplines as of 2023. With an ISSN of 1087-1845 and an E-ISSN of 1096-0937, the journal emphasizes the intersection of genetics and molecular biology to explore fundamental questions related to fungal biology that are of paramount importance to various applications in biotechnology, medicine, and environmental science. Researchers, professionals, and students alike will find this journal invaluable as it not only covers current trends and breakthroughs but also encourages collaborative efforts across the scientific community. Fungal Genetics and Biology continues to shape the future of fungal research well into 2024 and beyond, offering rich insights and open access options for a global audience.

The New Zealand Journal of Botany, published by the esteemed Taylor & Francis Ltd, serves as a pivotal platform for disseminating significant research in the fields of Ecology, Evolution, Behavior and Systematics, as well as Plant Science. With a rich history dating back to 1963 and an impressive convergence extending to 2024, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the complexities of plant life and ecological systems in New Zealand and beyond. The journal is currently categorized in the Q3 quartile for both relevant disciplines as of 2023, reflecting its balanced influence within the global academic community. Although not an open access journal, it retains a significant impact factor, evidenced by its Scopus rankings, which place it within the top half of its categories. This makes it an invaluable tool for students, researchers, and academics aiming to engage with robust, peer-reviewed scientific findings and contribute to the evolving discourse surrounding botany and ecological research.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.